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Objective: To present a case report of recurrent hypoglycaemia in type 2 diabetic patient due to hypothyroidism.
Methods: We describe a case with type 2 diabetes who complained of episodes of recurrent hypoglycaemia in last
few weeks. We also discuss the results of the diagnostic workup done to find out the cause of recurrent
hypoglycaemia.
Result: After ruling out common causes like overdosing of oral hypoglycaemic agents or insulin, renal or hepatic
impairment we found overt hypothyroidism as a cause of recurrent hypoglycaemia. Levothyroxine therapy was
started in this patient. Upon normalization of thyroid function, patient did not further experience any episodes of
hypoglycaemia. We did not find any report on hypothyroidism as a cause of recurrent hypoglycaemia in type 2
diabetic patients.
Conclusion: We conclude that during workup, clinicians should take hypothyroidism into consideration as a
potential cause of hypoglycaemia in type 2 diabetic patients.
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Hypoglycaemia is a common condition in diabetic pa-
tients. Prevalence of hypoglycaemia has been observed
in 12% of patients on diet alone followed by 16% and
30% in patients treated with oral hypoglycaemic agents
and insulin respectively [1]. Contrary to the belief that
hypoglycaemia is less common in type 2 diabetes, in a
study by Kasia et al. 9.3 - 13.8% type 2 diabetic patients
experienced hypoglycaemia irrespective of glycaemic
control whereas 10.8% patients experienced severe hy-
poglycaemia [2]. The most common causes of hypo-
glycaemia in diabetic patients are: overdosing of oral
hypoglycaemic agents or insulin with respect to meal
and physical activity, renal or hepatic impairment [3]. In
hypothyroidism gastrointestinal absorption of glucose
and its utilization in the peripheral tissues is slowed
[4-6]. Hepatic glucose output is decreased and insulin
half-life is prolonged [4-6]. Doses of exogenous insulin
may have to be decreased to avoid hypoglycaemia [5,6].
However, after treatment with levothyroxine when thyroid
function is normalized blood glucose levels may againCorrespondence: dralokkr@hotmail.com
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not considered as a most common cause of hypoglycaemia
in a type 2 diabetic patient. Here we present a case of re-
current hypoglycaemia in a type 2 diabetic patient diag-
nosed with overt hypothyroidism.Case presentation
In February 2014 a 73 years old male with type 2 dia-
betes for last 20 years visited our outpatient clinic. He
complained of episodes of recurrent hypoglycaemia in
last few weeks. His most recent blood glucose values in
his record book included many values of less than
70 mg/dl. Two days prior to his clinic visit patient expe-
rienced a severe episode of hypoglycaemia with blood
glucose value of 39 mg/dl from which he later recovered
by taking fast acting carbohydrates. During initial years
diabetes was managed with oral hypoglycaemic agents
[OHA’s]. After twelve years of OHA therapy, once daily
8 units of insulin glargine was added in the year 2006,
subsequently sulphonylurea and dipeptidyl peptidase – 4
[DPP-4] inhibitor were stopped. His glycemic control
remained satisfactory in the following years. Based on
his elevated HbA1C (11.2%) and results of home bloods an Open Access article distributed under the terms of the Creative Commons
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glulisine 8 units before each meal was started along with
insulin glargine 10 units once a day and metformin
500 mg twice daily. In the past two years his glycosylated
haemoglobin [HbA1C] ranged 7.9% to 9.4% and his in-
sulin doses almost remained the same.
On physical examination his body mass index [BMI]
was 22.72 kg/m2, blood pressure was 114/82 mmHg,
pulse rate was regular at 62 beats/ minute. No signifi-
cant change was noticed in the parameters during his
past follow up visits. His latest retinal examination in
January 2013 showed no evidence of diabetic retinopathy.
Further, based on his blood glucose monitoring, doses
of insulin glulisine were reduced to 4 units before each
meal and to 6 unit of insulin glargine once daily. Prelim-
inary biochemical investigations were done to find out
the cause of recurrent hypoglycaemia. Results of bio-
chemical results showed HbA1c - 7%, Normal renal pa-
rameters (urinary albumin to creatinine ratio = 5.04 mg/g
(normal < 30 mg/gm creatinine, serum creatinine was
0.85 mg/dl), serum alanine aminotransferase (SGPT) was
also in normal range 21 U/L (ref. Range 10–65 U/L), Free
thyroid function test revealed raised serum thyroid sti-
mulating hormone [TSH] ( 6.121 uIU/ml, ref. Range 0.5 –
4.780 uIU/ml ultrasensitive assay), low free T4 – 0.83 ng/dl
(ref. Range 0.89 – 1.76 ng/dl) and normal free T3 –
2.76 pg/ml (ref. range 2.3-4.2 pg/ml). TPO antibodies were
negative. Diagnosis of overt hypothyroidism was made and
patient started levothyroxine therapy. Six weeks later his
thyroid function normalized. Serum TSH was 3.733 uIU/
ml (ref. Range 0.5 – 4.780 uIU/ml ultrasensitive assay)
and serum Free T4 was 1.47 ng/dl (ref. Range 0.89 –
1.76 ng/dl). This patient did not have past history of thy-
roid dysfunction and three years back his serum TSH was
3.4 uIU/ml. After normalization of thyroid function pa-
tient did not experience any episode of hypoglycaemia,
although based on his self glucose monitoring values,
insulin doses were again increased to the same doses
that patient was taking earlier.
Discussion
Hypoglycaemia is usually seen in type 2 diabetic patients
who take sulphonylureas and insulin. In the case de-
scribed here we ruled out any change in patient’s recent
schedule, increase in physical activity, eating habits and
anti diabetic treatment induced hypoglycaemia. There
was no history of any drug interaction. Renal or hepatic
insufficiency was excluded. Although hypothyroidism is
not considered as one of the most common cause of
hypoglycaemia in routine clinical practice, in literature
there is a mention that hypothyroidism may cause
hypoglycaemia uncommonly [7]. In hypothyroidism, im-
portant factors that contribute to hypoglycaemia are
reduced insulin clearance, slow gastric emptying anddecreased intestinal absorption of glucose. Further, bio-
chemical effects like reduced gluconeogeneis, impaired
glycogenolysis and reduced glucagon secretion prevents
recovery from hypoglycaemia [6,8].
The prevalence of thyroid dysfunction in type 2
diabetics has been reported to be high [8-10]. After
assessing the thyroid function test diagnosis of overt
hypothyroidism was made because of the raised TSH
and low free T4. Patient was started on levothyroxine
therapy and further investigations were avoided due to
the economic constraint. Upon normalisation of thyroid
function in the last one month and later during subse-
quent follow up clinic visits for next six months patient
did not report any episodes of hypoglycaemia. Due to
raised glucose levels gradually insulin doses were in-
creased almost equal to the same doses which patient
was taking earlier.
Incidence of hypothyroidism in type 1 diabetic patients
is high and these patients are usually screened for thy-
roid dysfunction due to the autoimmune link. We did
not find any report on hypothyroidism as a cause of re-
current hypoglycaemia in type 2 diabetic patients.
Conclusion
In conclusion, we suggest that during diagnostic workup
clinicians should take hypothyroidism into consideration
as a potential cause of recurrent hypoglycaemia in type 2
diabetic patients.
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